EP PerMed 2025 Call "Pharmacogenomic strategies for personalised medicine approaches (PGxPM2025)" is Open for Application
The aim of the European Partnership for Personalised Medicine is to improve health outcomes within sustainable healthcare systems through research, development, innovation and implementation of personalised medicine approaches for the benefit of patients, citizens, and society.
The overall objectives of the JTC2025 will be to support research projects in human health on pharmacogenomic strategies for personalised medicine approaches that address one or more of the following aspects:
Identification of new pharmacogenomic markers or signatures using (multi)-omics data in relation to drug or drug combination.
Validation of a pharmacogenomic marker or signatures using (multi)-omics data in predicting drug or drug combination outcomes.
Use pharmaco-omics strategies to determine the right dosage, the efficacy of treatments and/or the risk of adverse drug response and non-response to treatment to tailor personalised treatment pathways, including combined treatments (multi-medication).
Detailed information about the call can be found in the Call document given below.
A two-step submission and evaluation procedure has been established for joint applications: In addition to international project applications to be submitted to the call secretariat, it is also mandatory for researchers from Türkiye to take part in the projects to submit a national project application to TÜBİTAK (https://uidb-pbs.tubitak.gov.tr).
Project proposals to be submitted from our country within the scope of this call will be supported within the scope of TÜBİTAK 1071 Support Program for Increasing the Capacity to Benefit from International Research Funds and Participation in International R&D Collaborations.
The national application rules has been given below.
Call Calendar:
Deadline for submission of stage 1 proposals to the Joint Call Secretariat: 18 February 2025 (13:00, CET)
Deadline for the TÜBİTAK national application of the stage 1 proposals: 28 February 2025 (23:59, UTC+3)
Deadline for submission of stage 2 proposals to the Joint Call Secretariat: 17 June 2025 (13:00, CET)
Call Contact Information:
EP PerMed and International application rules:
Assoc.Prof. Dr. N. Selcan TÜRKER
0312 2981760
TÜBİTAK 1071 program and national application rules:
Azmi Serhat YILDIRIM
azmiserhat.yildirim@tubitak.gov.tr
0312 2981823
